MiR-22-3p Regulates the Proliferation, Migration and Invasion of Colorectal Cancer Cells by Directly Targeting KDM3A Through the Hippo Pathway

Overview

Journal Histol Histopathol

Specialties Anatomy & Histology
Pathology

Date 2022 Sep 29

PMID 36173030

Authors

Rui-Ri Jin

Chunyan Zeng

Youxiang Chen

Affiliations

Soon will be listed here.

Abstract

Colorectal cancer (CRC) has one of the highest incidences and mortality rates of all malignancies worldwide. microRNAs (miRNAs) have been reported to be involved in many biological processes of diseases. MiR-22-3p is considered to be involved in cancer progression, but its role in CRC remains unclear. In this study, we detected that in CRC, the level of miR-22-3p is downregulated. MiR-22-3p has antitumor effects in CRC. miR-22-3p can reduce the proliferative, invasive and migrative capacity of CRC cells. Luciferase reporter analyses confirmed that KDM3A was a target of miR-22-3p, which can directly target the 3'UTR of KDM3A and decrease the expression of KDM3A in CRC cells. Our study also confirmed that KDM3A plays a role as an oncogene in CRC. KDM3A overexpression attenuated the tumor suppressor effects of miR-22-3p in CRC cells, demonstrating that miR-22-3p exerts antitumor effects by targeting KDM3A. Overexpression of miR-22-3p in CRC reduced YAP1 expression, whereas overexpression of KDM3A restored the expression of YAP1. In summary, miR-22-3p might inhibit the progression of CRC by targeting KDM3A to regulate the HIPPO signaling pathway, which may provide an opportunity for the treatment of CRC.

Citing Articles

Molecular Biology of Cancer-Interplay of Malignant Cells with Emerging Therapies.

Boussios S, Sheriff M, Ovsepian S Int J Mol Sci. 2024; 25(23).

PMID: 39684799 PMC: 11642048. DOI: 10.3390/ijms252313090.

Emerging roles of non-coding RNAs in modulating the PI3K/Akt pathway in cancer.

Hashemi M, Khosroshahi E, Asadi S, Tanha M, Ghatei Mohseni F, Abdolmohammad Sagha R Noncoding RNA Res. 2024; 10:1-15.

PMID: 39296640 PMC: 11406677. DOI: 10.1016/j.ncrna.2024.08.002.

Evaluation of the Relationship Between miRNA-22-3p and Gal-9 Levels in Glioblastoma.

Barut Z, Akdeniz F In Vivo. 2023; 37(6):2577-2584.

PMID: 37905655 PMC: 10621420. DOI: 10.21873/invivo.13365.

MiR-22-3p suppresses NSCLC cell migration and EMT via targeting RAC1 expression.

Wang X, Wang X, Jiang T, Zhang Z, Xie N, Yang G Funct Integr Genomics. 2023; 23(3):281.

PMID: 37620594 PMC: 10449966. DOI: 10.1007/s10142-023-01211-z.

USP20 is a predictor of poor prognosis in colorectal cancer and associated with lymph node metastasis, immune infiltration and chemotherapy resistance.

Jin R, Luo Z, Jun-Li , Tao Q, Wang P, Cai X Front Oncol. 2023; 13:1023292.

PMID: 36874086 PMC: 9978104. DOI: 10.3389/fonc.2023.1023292.

References

Agarwal V, Bell G, Nam J, Bartel D . Predicting effective microRNA target sites in mammalian mRNAs. Elife. 2015; 4. PMC: 4532895. DOI: 10.7554/eLife.05005. View

Barrett T, Wilhite S, Ledoux P, Evangelista C, Kim I, Tomashevsky M . NCBI GEO: archive for functional genomics data sets--update. Nucleic Acids Res. 2012; 41(Database issue):D991-5. PMC: 3531084. DOI: 10.1093/nar/gks1193. View

Cao Y, Wang Z, Yan Y, Ji L, He J, Xuan B . Enterotoxigenic Bacteroidesfragilis Promotes Intestinal Inflammation and Malignancy by Inhibiting Exosome-Packaged miR-149-3p. Gastroenterology. 2021; 161(5):1552-1566.e12. DOI: 10.1053/j.gastro.2021.08.003. View

Chandrashekar D, Bashel B, Balasubramanya S, Creighton C, Ponce-Rodriguez I, Chakravarthi B . UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses. Neoplasia. 2017; 19(8):649-658. PMC: 5516091. DOI: 10.1016/j.neo.2017.05.002. View

Chen Y, Wang X . miRDB: an online database for prediction of functional microRNA targets. Nucleic Acids Res. 2019; 48(D1):D127-D131. PMC: 6943051. DOI: 10.1093/nar/gkz757. View

Cho Y, Li S, Wang X, Zhu J, Zhuo S, Han Y . CDK7 regulates organ size and tumor growth by safeguarding the Hippo pathway effector Yki/Yap/Taz in the nucleus. Genes Dev. 2019; 34(1-2):53-71. PMC: 6938674. DOI: 10.1101/gad.333146.119. View

Cong J, Gong J, Yang C, Xia Z, Zhang H . miR-22 Suppresses Tumor Invasion and Metastasis in Colorectal Cancer by Targeting NLRP3. Cancer Manag Res. 2020; 12:5419-5429. PMC: 7351629. DOI: 10.2147/CMAR.S255125. View

Dandawate P, Ghosh C, Palaniyandi K, Paul S, Rawal S, Pradhan R . The Histone Demethylase KDM3A, Increased in Human Pancreatic Tumors, Regulates Expression of DCLK1 and Promotes Tumorigenesis in Mice. Gastroenterology. 2019; 157(6):1646-1659.e11. PMC: 6878178. DOI: 10.1053/j.gastro.2019.08.018. View

Ding X, Li Z, Peng K, Zou R, Wu C, Lin G . Snail regulates Hippo signalling-mediated cell proliferation and tissue growth in . Open Biol. 2022; 12(3):210357. PMC: 8905163. DOI: 10.1098/rsob.210357. View

10.

Edgar R, Domrachev M, Lash A . Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 2001; 30(1):207-10. PMC: 99122. DOI: 10.1093/nar/30.1.207. View

11.

Gorur A, Bayraktar R, Ivan C, Mokhlis H, Bayraktar E, Kahraman N . ncRNA therapy with miRNA-22-3p suppresses the growth of triple-negative breast cancer. Mol Ther Nucleic Acids. 2021; 23:930-943. PMC: 7868999. DOI: 10.1016/j.omtn.2021.01.016. View

12.

Guan B, Ma J, Yang Z, Yu F, Yao J . LncRNA NCK1-AS1 exerts oncogenic property in gastric cancer by targeting the miR-22-3p/BCL9 axis to activate the Wnt/β-catenin signaling. Environ Toxicol. 2021; 36(8):1640-1653. DOI: 10.1002/tox.23160. View

13.

Han M, Wang S, Fritah S, Wang X, Zhou W, Yang N . Interfering with long non-coding RNA MIR22HG processing inhibits glioblastoma progression through suppression of Wnt/β-catenin signalling. Brain. 2020; 143(2):512-530. PMC: 7009478. DOI: 10.1093/brain/awz406. View

14.

Hu Y, French S, Chau T, Liu H, Sheng L, Wei F . RARβ acts as both an upstream regulator and downstream effector of miR-22, which epigenetically regulates NUR77 to induce apoptosis of colon cancer cells. FASEB J. 2018; 33(2):2314-2326. PMC: 6338632. DOI: 10.1096/fj.201801390R. View

15.

Jiang Q, Zheng N, Bu L, Zhang X, Zhang X, Wu Y . SPOP-mediated ubiquitination and degradation of PDK1 suppresses AKT kinase activity and oncogenic functions. Mol Cancer. 2021; 20(1):100. PMC: 8340461. DOI: 10.1186/s12943-021-01397-5. View

16.

Jin L, Chen Y, Cheng D, He Z, Shi X, Du B . YAP inhibits autophagy and promotes progression of colorectal cancer via upregulating Bcl-2 expression. Cell Death Dis. 2021; 12(5):457. PMC: 8105309. DOI: 10.1038/s41419-021-03722-8. View

17.

Khamas A, Ishikawa T, Shimokawa K, Mogushi K, Iida S, Ishiguro M . Screening for epigenetically masked genes in colorectal cancer Using 5-Aza-2'-deoxycytidine, microarray and gene expression profile. Cancer Genomics Proteomics. 2012; 9(2):67-75. View

18.

Kim M, Ly S, Xie Y, Duronio G, Ford-Roshon D, Hwang J . YAP1 and PRDM14 converge to promote cell survival and tumorigenesis. Dev Cell. 2022; 57(2):212-227.e8. PMC: 8827663. DOI: 10.1016/j.devcel.2021.12.006. View

19.

Kozomara A, Birgaoanu M, Griffiths-Jones S . miRBase: from microRNA sequences to function. Nucleic Acids Res. 2018; 47(D1):D155-D162. PMC: 6323917. DOI: 10.1093/nar/gky1141. View

20.

Liu J, Liang T, Zhangsun W . KDM3A is associated with tumor metastasis and modulates colorectal cancer cell migration and invasion. Int J Biol Macromol. 2018; 126:318-325. DOI: 10.1016/j.ijbiomac.2018.12.105. View